Danaher (DHR) reported fiscal Q1 non-GAAP net earnings Tuesday of $1.88 per diluted share, down from $1.92 a year earlier.
Analysts polled by FactSet expected $1.63.
Sales for the fiscal quarter ended March 28 were $5.74 billion, down from $5.80 billion a year earlier.
Analysts surveyed by FactSet expected $5.57 billion.
For fiscal 2025, the life sciences company expects adjusted diluted EPS of $7.60 to $7.75.
Analysts polled by FactSet expect $7.66.
Shares of the company were up more than 2% in recent premarket activity.
Price: 190.00, Change: +5.04, Percent Change: +2.72
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。